Assessment of multiplex detection method for JAK2, MPL and CALR in PV, ET and MF patients

Assessment of multiplex detection method for JAK2, MPL and CALR in PV, ET and MF patients - CHIBA MPN study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029725

Enrollment

Registered

2017-10-26

Start date

2017-08-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycythemia vera, Essential thorombocythemia, Myelofibrosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: PV, ET and MF patients

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The sensitivity and specificity of novel technique to identify JAK2, MPL and CALR mutation	—

Countries

Japan

Contacts

Public ContactMasahiro Takeuchi

Chiba University Hospital Department of Hematolgy

m-takeuchi@faculty.chiba-u.jp043-222-7171

Outcome results